William K. Heiden, CEO at AMAG PHARMACEUTICALS INC. (AMAG), sold 66,875 shares at $69.77 ($4.7M) on 2015-06-05, disclosed to the SEC on 2015-06-08.
Scheduled sale ($4.7M) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.14 | 6,875 | $468K | 10.0% |
| 2 | $68.90 | 6,642 | $458K | 9.8% |
| 3 | $69.77 | 36,550 | $2.6M | 54.6% |
| 4 | $70.69 | 4,680 | $331K | 7.1% |
| 5 | $71.52 | 12,128 | $867K | 18.6% |
| Total | $69.90 avg | 66,875 |
| $4.7M |
| 100% |
| Filing → |
| AMAG | BUY | 2019-05-09 | $107K | — | Filing → |
| AMAG | SELL | 2018-08-08 | $125K | — | Filing → |
| AMAG | SELL | 2018-06-05 | $500K | — | Filing → |